全部 标题 作者 关键词 摘要
DOI: 10.3748/wjg.v25.i7.789
Keywords: Hepatocellular carcinoma, Molecular targeted agent, Immune checkpoint inhibitor, Sorafenib, Lenvatinib
Full-Text Cite this paper Add to My Lib
Full-Text
Contact Us
service@oalib.com
QQ:3279437679
WhatsApp +8615387084133
WeChat 1538708413